3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
5
Thoracic Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Non-small Lung Cancer
1
Neoplasms by Site
1
Neoplasms
1
Lung Neoplasms
1
Lung Diseases
1
Carcinoma, Bronchogenic
1
Carcinoma
1
Breast Neoplasms
1
Interventions
Carboplatin
5
pembrolizumab
4
Paclitaxel
3
selpercatinib
2
durvalumab
2
Pemetrexed
2
Cisplatin
2
taletrectinib
1
repotrectinib
1
pralsetinib
1
pegylated granulocyte colony-stimulating factor
1
efineptakin alfa
1
ceralasertib
1
cemiplimab
1
atezolizumab
1
Telescopes
1
Radiosurgery
1
Nivolumab
1
Magnetic Resonance Imaging
1
Kyphoplasty
1
Injections, Epidural
1
Gemcitabine
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thoracic Neoplasms
×
taletrectinib
×
1 year
×
Clear all
NCT06841874
2025-12-24
Tale EAP
Nuvation Bio Inc.
No longer available